CD274 and cancer: Whilst PD-L1 expression has also shown variable prognostic value in several cancers, with conflicting evidence [45,46,47,48,49,50], its expression assessed with CPS is the prerequisite for the administration of therapy, and awareness and control of factors that can influence PD-L1 expression are of preeminent importance to avoid misinterpretation of this marker.